These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26907087)

  • 1. Creatine target engagement with brain bioenergetics: a dose-ranging phosphorus-31 magnetic resonance spectroscopy study of adolescent females with SSRI-resistant depression.
    Kondo DG; Forrest LN; Shi X; Sung YH; Hellem TL; Huber RS; Renshaw PF
    Amino Acids; 2016 Aug; 48(8):1941-54. PubMed ID: 26907087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: a 31-phosphorus magnetic resonance spectroscopy study.
    Kondo DG; Sung YH; Hellem TL; Fiedler KK; Shi X; Jeong EK; Renshaw PF
    J Affect Disord; 2011 Dec; 135(1-3):354-61. PubMed ID: 21831448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain bioenergetics and response to triiodothyronine augmentation in major depressive disorder.
    Iosifescu DV; Bolo NR; Nierenberg AA; Jensen JE; Fava M; Renshaw PF
    Biol Psychiatry; 2008 Jun; 63(12):1127-34. PubMed ID: 18206856
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sex-Based Impact of Creatine Supplementation on Depressive Symptoms, Brain Serotonin and SSRI Efficacy in an Animal Model of Treatment-Resistant Depression.
    Kanekar S; Ettaro R; Hoffman MD; Ombach HJ; Brown J; Lynch C; Sheth CS; Renshaw PF
    Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of Creatine Monohydrate Augmentation on Brain Metabolic and Network Outcome Measures in Women With Major Depressive Disorder.
    Yoon S; Kim JE; Hwang J; Kim TS; Kang HJ; Namgung E; Ban S; Oh S; Yang J; Renshaw PF; Lyoo IK
    Biol Psychiatry; 2016 Sep; 80(6):439-447. PubMed ID: 26822799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Open-Label Pilot Study of Combined Augmentation With Creatine Monohydrate and 5-Hydroxytryptophan for Selective Serotonin Reuptake Inhibitor- or Serotonin-Norepinephrine Reuptake Inhibitor-Resistant Depression in Adult Women.
    Kious BM; Sabic H; Sung YH; Kondo DG; Renshaw P
    J Clin Psychopharmacol; 2017 Oct; 37(5):578-583. PubMed ID: 28787372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Selective serotonin reuptake inhibitors in major depressive disorder in children and adolescents (ratio of benefits/risks)].
    Hjalmarsson L; Corcos M; Jeammet P
    Encephale; 2005; 31(3):309-16. PubMed ID: 16142045
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, double-blind placebo-controlled trial of oral creatine monohydrate augmentation for enhanced response to a selective serotonin reuptake inhibitor in women with major depressive disorder.
    Lyoo IK; Yoon S; Kim TS; Hwang J; Kim JE; Won W; Bae S; Renshaw PF
    Am J Psychiatry; 2012 Sep; 169(9):937-945. PubMed ID: 22864465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multinuclear magnetic resonance spectroscopy of high-energy phosphate metabolites in human brain following oral supplementation of creatine-monohydrate.
    Lyoo IK; Kong SW; Sung SM; Hirashima F; Parow A; Hennen J; Cohen BM; Renshaw PF
    Psychiatry Res; 2003 Jun; 123(2):87-100. PubMed ID: 12850248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study.
    Chen Y; Cao X; Zang W; Tan S; Ou CQ; Shen X; Gao T; Zhao L
    Trials; 2019 Jan; 20(1):34. PubMed ID: 30626424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Edivoxetine compared to placebo as adjunctive therapy to selective serotonin reuptake inhibitors in the prevention of symptom re-emergence in major depressive disorder.
    Oakes TM; Dellva MA; Waterman K; Greenbaum M; Poppe C; Goldberger C; Ahl J; Perahia DG
    Curr Med Res Opin; 2015 Jun; 31(6):1179-89. PubMed ID: 25894953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cAMP signaling in brain is decreased in unmedicated depressed patients and increased by treatment with a selective serotonin reuptake inhibitor.
    Fujita M; Richards EM; Niciu MJ; Ionescu DF; Zoghbi SS; Hong J; Telu S; Hines CS; Pike VW; Zarate CA; Innis RB
    Mol Psychiatry; 2017 May; 22(5):754-759. PubMed ID: 27725657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacy and medical costs associated with switching between venlafaxine and SSRI antidepressant therapy for the treatment of major depressive disorder.
    Khandker RK; Kruzikas DT; McLaughlin TP
    J Manag Care Pharm; 2008 Jun; 14(5):426-41. PubMed ID: 18597572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Similarities of biochemical abnormalities between major depressive disorder and bipolar depression: a proton magnetic resonance spectroscopy study.
    Zhong S; Wang Y; Zhao G; Xiang Q; Ling X; Liu S; Huang L; Jia Y
    J Affect Disord; 2014 Oct; 168():380-6. PubMed ID: 25106035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Creatine as a Novel Treatment for Depression in Females Using Methamphetamine: A Pilot Study.
    Hellem TL; Sung YH; Shi XF; Pett MA; Latendresse G; Morgan J; Huber RS; Kuykendall D; Lundberg KJ; Renshaw PF
    J Dual Diagn; 2015; 11(3-4):189-202. PubMed ID: 26457568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of selective serotonin reuptake inhibitors in healthy first-degree relatives of patients with major depressive disorder - an experimental medicine blinded controlled trial.
    Knorr UB
    Dan Med J; 2012 Apr; 59(4):B4426. PubMed ID: 22459724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjunctive quetiapine for treatment-resistant adolescent major depressive disorder: a case series.
    Pathak S; Johns ES; Kowatch RA
    J Child Adolesc Psychopharmacol; 2005 Aug; 15(4):696-702. PubMed ID: 16190801
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ziprasidone augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant major depressive disorder.
    Papakostas GI; Petersen TJ; Nierenberg AA; Murakami JL; Alpert JE; Rosenbaum JF; Fava M
    J Clin Psychiatry; 2004 Feb; 65(2):217-21. PubMed ID: 15003076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.
    Lenox-Smith AJ; Jiang Q
    Int Clin Psychopharmacol; 2008 May; 23(3):113-9. PubMed ID: 18408525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.